Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytes

被引:1
|
作者
Mittendorff, Claudia [1 ]
Abu-Taha, Issam [1 ]
Kassler, Lena [1 ]
Hustedt, Tobias [2 ,3 ]
Wolf, Stephanie [2 ,3 ]
Bode, Johannes G. [2 ,3 ]
Kamler, Markus [4 ]
Dobrev, Dobromir [1 ,5 ,6 ,7 ,8 ]
Fender, Anke C. [1 ]
机构
[1] Univ Duisburg Essen, Inst Pharmacol, West German Heart & Vasc Ctr, Duisburg, Germany
[2] Heinrich Heine Univ, Fac Med, Dept Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany
[3] Heinrich Heine Univ, Dusseldorf Univ Hosp, Dusseldorf, Germany
[4] Univ Hosp Essen, Dept Thorac & Cardiovasc Surg, Essen, Germany
[5] Montreal Heart Inst, Dept Med, Montreal, PQ, Canada
[6] Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada
[7] Univ Montreal, Montreal, PQ, Canada
[8] Baylor Coll Med, Dept Integrat Physiol, Houston, TX USA
基金
美国国家卫生研究院;
关键词
Atrial; Cardiomyocyte; C-met; NLRP3; inflammasome; Protease-activated receptor; Thrombin; EXPRESSION; TARGET; CELLS;
D O I
10.1007/s00210-024-03436-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Thrombin supports coagulation-independent inflammation via protease-activated receptors (PAR). PAR4 is specifically increased in obese human atria, correlating with NLRP3 inflammasome activation. PAR4-mediated NLRP3 inflammasome activation in atrial cardiomyocytes is not known, nor have signaling partners been identified. Thrombin transactivates the hepatocyte growth factor receptor in some cancer cells, so we examined PAR4/c-met cross-talk in atrial cardiomyocytes and its possible significance in obesity. Cardiomyocytes from right atrial appendages (RAA) of obese patients expressed more PAR1 and PAR4 compared to non-obese. In HL-1 atrial cardiomyocytes, thrombin induced caspase-1 auto-activation and IL-1 beta maturation; IL-1 beta secretion was evoked by PAR4-activating peptide (AP), but not PAR1-AP. PAR4-AP additionally increased phosphorylated CaMKII-Thr287, mTOR-Ser2481, and Akt-Ser473 while suppressing AMPK-Thr172 phosphorylation. Total kinase levels were largely unaltered. PAR4AP rapidly increased phosphorylated c-met in HL-1 cells and over time also transcriptionally upregulated c-met. The c-met inhibitor SGX-523 abrogated the effects of PAR4-AP on CaMKII/AKT/mTOR phosphorylation but did not affect PAR4-stimulated IL-1 beta production. Obese human RAA contained more IL-1 beta, phospho-c-met, and phospho-mTOR than non-obese RAA; CamKII phosphorylation was not modified. Atria from high-fat diet (HFD) versus chow-fed mice also contained more IL-1 beta, together with higher myeloperoxidase activity, Acta2 mRNA total and phosphorylated c-met; these increases were blunted in PAR4-/- HFD-fed mice. Thrombin cross-activates c-met via PAR4 in atrial cardiomyocytes. Transactivated c-met contributes partially to PAR4-mediated signaling, but NLRP3 inflammasome activation appears to be largely independent of c-met. Abundance of PAR4 and activated c-met increases with obesity, providing therapeutic targets for management of adiposity-driven AF.
引用
收藏
页码:2783 / 2796
页数:14
相关论文
共 50 条
  • [1] Thrombin receptor PAR4 transactivates the receptor tyrosine kinase c-met in atrial myocardium
    Mittendorf, C.
    Abu-Taha, I.
    Kamler, M.
    Dobrev, D.
    Fender, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S3 - S3
  • [2] In vivo imaging of c-Met receptor tyrosine kinase using c-Met binding peptide
    Kim, Eun-Mi
    Park, Eun-Hye
    Lee, Chang-Moon
    Cheong, Su-Jin
    Kim, Dong-Wook
    Lim, Seok Tae
    Sohn, Myung-Hee
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [3] TYROSINE KINASE RECEPTOR INDISTINGUISHABLE FROM THE C-MET PROTEIN
    GIORDANO, S
    PONZETTO, C
    DIRENZO, MF
    COOPER, CS
    COMOGLIO, PM
    NATURE, 1989, 339 (6220) : 155 - 156
  • [4] Role of c-Met receptor tyrosine kinase in lung cancer
    Ma, PC
    Ramasamy, J
    Seiwert, T
    Tretiakova, MS
    Husain, AN
    Puri, N
    Salgia, R
    LUNG CANCER, 2004, 46 : S8 - S9
  • [5] Expression and activation of c-Met receptor tyrosine kinase in malignant mesothelioma
    Husain, AN
    Krausz, T
    Tretiakova, M
    Kratzke, R
    Ma, PC
    Salgia, R
    MODERN PATHOLOGY, 2005, 18 : 312A - 312A
  • [6] Expression and activation of c-Met receptor tyrosine kinase in malignant mesothelioma
    Husain, AN
    Krausz, T
    Trekiakova, M
    Kratzke, R
    Ma, PC
    Salgia, R
    LABORATORY INVESTIGATION, 2005, 85 : 312A - 312A
  • [7] Biological significance and targeting of c-Met tyrosine kinase receptor in cancer
    Goetsch, Liliane
    Caussanel, Veronique
    Corvaia, Nathalie
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 454 - 473
  • [8] ROLE OF HGF/C-MET RECEPTOR TYROSINE KINASE IN LUNG CANCER
    Ma, Patrick C.
    Ramasamy, Jagadeeswaran
    Seiwert, Tanguy
    Nallasura, Vidya
    Ahmed, Salman
    Uppalapati, Radha
    Varalakshmi, Janamanchi
    Puri, Neelu
    Salgia, Ravi
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3618 - 3619
  • [9] The Receptor Tyrosine Kinase, AXL, Regulates c-MET in Epithelial Ovarian Cancer
    Fuh, Katherine C.
    Rankin, Erinn B.
    Longacre, Teri
    Kariolis, Mihalis
    Cochran, Jennifer
    Giaccia, Amato
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 93A - 94A
  • [10] Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
    Zhang, Yazhuo
    Xia, Mengfang
    Jin, Ke
    Wang, Shufei
    Wei, Hang
    Fan, Chunmei
    Wu, Yingfen
    Li, Xiaoling
    Li, Xiayu
    Li, Guiyuan
    Zeng, Zhaoyang
    Xiong, Wei
    MOLECULAR CANCER, 2018, 17